ada standards of care 2025 glp-1 receptor agonists recommendations Ten Top Tips for the Management in Adults within Primary American Diabetes Association Insights |

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

GLP-1 is a peptide hormone secreted by L cells in the ileum and colon

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Supports gut lining integrity

Allulose in human diet: the knowns and the unknowns - Volume 128 Issue 2